bevacizumab,cetuximab
roche,eli lilly
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'fire-4', 'congrat']
today at #asco22 #crc poster discussion: how to handle #antiegfr #rechallenge in #crc? including results of the phase iii trial fire-4, discussed by and colleagues . congratulations! 
We connect medical oncologists and young residents interested in medical oncology to collaborate in research and evolve cancer medicine.